Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StemEx expanded umbilical cord blood transplantation after myeloablative therapy
2006-005159-14Phase 3Completed
- Sponsor
- Gamida Cell
- Start
- Dec 2007
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of carlecortemcel-l in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Gamida Cell. Started Dec 2007; status: completed.
02
Drugs
carlecortemcel-l
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myelogenous leukemia (CML)non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on 2006-005159-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005159-14.